CC-AMC Pilot Awards in HIV-Associated Malignancies
Disclaimer: The funding for this award is subject to the receipt of the NCI competing renewal award for the parent P30 grant of the Helen Diller Family Comprehensive Cancer Center (CC). The award is expected to be received by the fall. Based on ongoing discussions with the NCI, the CC has every expectation that they will award the grant and fund the CC-AMC Pilot Award. In the extremely unlikely situation that the award is not received by the fall, the CC-AMC Pilot Award program will not be funded. If you are planning on applying for this award, it is strongly recommended that you notify Jordan Brainerd, firstname.lastname@example.org, to let the CC know of your intention to submit a proposal. When there is an update available on the funding status, Ms. Brainerd will immediately notify all potential applicants.
Project award amount: 2 Awards of $100,000
Description: Malignancies constitute a substantial source of morbidity and mortality among HIV-infected persons, even in the era of anti-retroviral therapy. AIDS-defining malignancies (Kaposi's sarcoma, nonHodgkins lymphoma, cervical cancer) continue to develop in HIV-infected persons, particularly in developing countries, and the incidence of non-AIDS defining malignancies (NADM) is growing among HIV-infected men and women. Funding is available through the Helen Diller Family Comprehensive Cancer Center (CC) to foster the development of the next generation of researchers working in the field of HIV-related malignancies, in collaboration with the NCI-supported AIDS Malignancy Consortium (AMC).
Proposals considered responsive to this request for applications will be those that focus on maximizing the scientific productivity and correlative science of existing AMC protocols, or establish novel lines of investigation that may lead to the development of new AMC protocols. CC investigators new to HIV-related malignancies research must collaborate with AMC investigators/mentors. AMC investigators must collaborate with CC investigators/mentors. Investigators who are not part of the CC or AMC are also encouraged to apply, after being paired with the appropriate CC and AMC project leaders and co-project leaders, respectively. The proposals may focus either on AIDS-defining malignancies or non-AIDS-defining malignancies. Applicants are encouraged to contact one of the faculty listed below who are engaged in AMC activities for further information.
CC-AMC Pilot awards seek to provide opportunities to junior scientists to obtain the requisite mentored research experience and training to compete for career-development funds. Project proposals should be geared toward the interests of the applicant (clinical, basic, and/or behavioral-epidemiological research) and focus on topics relevant to the CC and AMC mission. Applicants for this award must identify BOTH CC AND AMC faculty research mentors who will commit to guiding the applicant through the duration of the proposed project.
Eligibility: Researchers with academic appointments at all levels (excluding faculty without pay) are eligible. Post-doctoral fellows are not eligible. A UCSF CC and AMC faculty research mentor must be named on the project. The mentors' role is to provide oversight on the planning, direction, and execution of the proposal. The mentors should be recognized as accomplished investigators in cancer research, and should be able to demonstrate past success in training/mentoring independent investigators. In addition, the mentors must commit to mentoring the applicant for the duration of the research project.
Criteria for Review/Evaluation of Applications: Applications that are complete and meet eligibility requirements will be evaluated for scientific and technical merit by an appropriate review committee convened by the UCSF Resource Allocation Program in accordance with the review criteria employed by the NIH which include five core areas: 1. Significance, 2. Approach, 3. Innovation, 4. Investigator, 5. Environment. Each of these criteria will be addressed and considered in assigning the overall score weighing them as appropriate for each application.
For information about the AIDS Malignancy Consortium program:
For information about the Helen Diller Family Comprehensive Cancer Center:
The CFAR Andy I. Choi Mentoring Program:
For a list of Cancer Center faculty:
For information on the Cancer Center’s Cancer, Immunity and the Microenvironment Program: